Literature DB >> 15675950

Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts.

Masatoshi Jinnin1, Hironobu Ihn, Yoshihiro Mimura, Yoshihide Asano, Kenichi Yamane, Kunihiko Tamaki.   

Abstract

We investigated the direct effect of hepatocyte growth factor (HGF) on the expression of type I collagen in normal and scleroderma dermal fibroblasts, and analyzed the mechanisms underlying the effect in vitro. HGF did not change the protein expression of type I procollagen in the medium of normal human fibroblasts, whereas it reduced the expression in scleroderma fibroblasts. But mRNA levels and the promoter activity of alpha2(I) collagen gene were not significantly affected by HGF in either of the cells. On the other hand, matrix metalloproteinase-1 expression or activity was increased by HGF in both cells, but HGF had stronger effects in scleroderma fibroblasts than normal fibroblasts. Scleroderma fibroblasts overexpressed c-met protein, the receptor for HGF. The overexpression in scleroderma fibroblasts was abolished by the addition of antisense transforming growth factor (TGF)-beta1 oligonucleotide. Our study indicated that HGF may reduce type I collagen accumulation only in scleroderma fibroblasts by enhancing collagenolysis activity, probably because of the overexpression of c-met because of autocrine TGF-beta signaling. Thus, further investigation of the effects of HGF on collagen metabolism may contribute to the treatment of fibrosis in scleroderma.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15675950     DOI: 10.1111/j.0022-202X.2004.23601.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

Review 1.  The impact of Fli1 deficiency on the pathogenesis of systemic sclerosis.

Authors:  Yoshihide Asano; Andreea M Bujor; Maria Trojanowska
Journal:  J Dermatol Sci       Date:  2010-07-03       Impact factor: 4.563

2.  Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.

Authors:  Pankaj K Singh; Michelle E Behrens; John P Eggers; Ronald L Cerny; Jennifer M Bailey; Kandavel Shanmugam; Sandra J Gendler; Eric P Bennett; Michael A Hollingsworth
Journal:  J Biol Chem       Date:  2008-07-14       Impact factor: 5.157

Review 3.  Molecular pathogenesis of skin fibrosis: insight from animal models.

Authors:  Gideon P Smith; Edwin S L Chan
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

4.  Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-β1 signaling in interstitial lung disease.

Authors:  Shibnath Ghatak; Galina S Bogatkevich; Ilia Atnelishvili; Tanjina Akter; Carol Feghali-Bostwick; Stanley Hoffman; Victor M Fresco; John C Fuchs; Richard P Visconti; Roger R Markwald; Subhas B Padhye; Richard M Silver; Vincent C Hascall; Suniti Misra
Journal:  J Biol Chem       Date:  2013-12-09       Impact factor: 5.157

5.  Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.

Authors:  Minghua Wu; Denisa S Melichian; Eric Chang; Matthew Warner-Blankenship; Asish K Ghosh; John Varga
Journal:  Am J Pathol       Date:  2009-01-15       Impact factor: 4.307

6.  Abnormalities in the regulators of angiogenesis in patients with scleroderma.

Authors:  Laura K Hummers; Amy Hall; Fredrick M Wigley; Michael Simons
Journal:  J Rheumatol       Date:  2009-02-17       Impact factor: 4.666

Review 7.  In perspective: murine models of scleroderma.

Authors:  Minghua Wu; John Varga
Journal:  Curr Rheumatol Rep       Date:  2008-07       Impact factor: 4.592

8.  Inhibition of Wnt/β-catenin signaling suppresses bleomycin-induced pulmonary fibrosis by attenuating the expression of TGF-β1 and FGF-2.

Authors:  Xiang Chen; Chaowen Shi; Xiannan Meng; Kaijia Zhang; Xiaoyao Li; Cong Wang; Zou Xiang; Kebin Hu; Xiaodong Han
Journal:  Exp Mol Pathol       Date:  2016-04-23       Impact factor: 3.362

9.  Age-related elevation of HGF is driven by the reduction of fibroblast size in a YAP/TAZ/CCN2 axis-dependent manner.

Authors:  Yaping Xiang; Zhaoping Qin; Yan Yang; Gary J Fisher; Taihao Quan
Journal:  J Dermatol Sci       Date:  2021-02-16       Impact factor: 4.563

10.  Abnormally differentiating keratinocytes in the epidermis of systemic sclerosis patients show enhanced secretion of CCN2 and S100A9.

Authors:  Joanna Nikitorowicz-Buniak; Xu Shiwen; Christopher P Denton; David Abraham; Richard Stratton
Journal:  J Invest Dermatol       Date:  2014-06-16       Impact factor: 8.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.